cliexa is a finalist for the Health Tech Venture Challenge

cliexa makes the finals of the Health Tech Venture Challenge, thanks to Advocate Aurora Health and MATTER.

On November 28, Advocate Aurora Health and MATTER announced the finalists for the Health Tech Venture Challenge. cliexa was selected as one of the five finalists who will have the opportunity to pitch their healthcare technology solutions to leaders and executives from Advocate Aurora Health at MATTER in Chicago on Tuesday, December 11, 2018.

The main goal of this challenge was “how might we transform the primary care experience?” cliexa submitted an application in November to highlight how our solutions can be applied in a primary care setting to transform and improve the patient and provider experience.

The cliexa platform enables physicians and hospitals to fully leverage patient-reported data to improve clinical care and outcomes while maximizing reimbursement. Healthcare providers can seamlessly leverage clinically validated scoring and assessment models and incorporate patient-reported data into EMR systems.

We are very much looking forward to the event. More updates to come following the finals in December.

Here is the link to the announcement: https://matter.health/posts/health-tech-venture-challenge-finalists-to-pitch-their-solutions-to-advocate-aurora-health-leaders/

cliexa is a semifinalist in the AHRQ's Step-Up Challenge

cliexa is a semifinalist in the AHRQ's Step-Up Challenge

cliexa is one of 10 companies out of 50+ advancing to Phase 2 of the Agency for Healthcare Research and Quality (AHRQ)‘s Step-Up App Challenge with the “goal of developing an app that integrates standardized patient-reported outcomes (PRO) data into clinical care and research.”

For Phase 2 of the Step Up App Challenge, cliexa will design, develop, and demo our application using the FHIR technical specifications and PROMIS® resources for patient-reported outcomes with the hope to be selected as one of the three winners, who will get the opportunity to test their product in nine practice settings affiliated with MedStar Health in Washington, DC.

Read the blog announcing the 10 semifinalists from Director of the AHRQ, Gopal Khanna, M.B.A: https://www.ahrq.gov/news/blog/ahrqviews/stepup-challenge-finalists.html

Check out our portfolio of patient-reported outcomes applications: cliexa Mobile

cliexa PTSI Press Release

We are proud to announce that we have officially joined forces with Preventative Technology Solutions, who will now become apart of the cliexa family.

Here is the link to the press release about the acquisition: //www.pr.com/press-release/768313

 

cliexaRA Press Release

cliexa® partners with the Colorado Arthritis Center to identify how screening and monitoring of Rheumatoid Arthritis patients through a customized electronic platform, cliexa-RA, impacts clinical efficiency.

See the full press release from PR.com: https://www.pr.com/press-release/765307

Download the Case Study here: https://www.cliexa.com/cliexa-ra-case-study/

Learn more about cliexa-RA: https://www.cliexa.com/cliexamobile/rheumatoid-arthritis/

cliexa® partners with the University of Colorado Boulder’s Cognitive and Affective Neuroscience Lab (CANLab) for Multidimensional Pain Tracking and Predictive Analytics Research.
cliexa® Partners with Institute of Cognitive Science at University of Colorado Boulder

Denver, CO, February 28, 2018 — cliexa, Inc., which offers a suite of mobile platforms for chronic disease management, announces its collaboration with CU Boulder’s CANLab and Institute of Cognitive Science (ICS). cliexa will collaborate with CANLab’s team, headed by Tor Wager, a professor of psychology and neuroscience, as they lead in multidimensional pain tracking and predictive analytics research.

CU Boulder jointly filed a provisional patent with cliexa for the multidimensional objective pain concept with CANLab. CANLab focuses on identifying a particular pattern of brain activity, which is diagnostic of physical pain. cliexa-Ease’s mobile platform hosts the research concept and is being used to further develop CANLab’s existing pain studies. cliexa-Ease will deliver an exclusive pain assessment model which, in collaboration with CU Boulder, anticipates commercialization by mid 2018.

Mehmet Kazgan, founder and CEO of cliexa, explains how they are excited about the partnership with Wager’s CANLab because of its “leading research studies for multidimensional pain tracking.” “Working with neuroscientists at CU Boulder is taking the cliexa platform to the next level of objectifying patient outputs with multiple reference points.”

Wager highlights how the collaboration will “expand our ability to understand how emotion affects pain in daily life.” Pavel Goldstein, the scientific lead of the project, adds that the partnership will provide both “an incredible opportunity to establish a platform for researching chronic pain conditions” and “important feedback to pain patients and their clinicians with unique information about patient health.”

About The Cognitive and Affective Neuroscience Lab

Professor Tor Wager leads CANLab, which is housed in CU Boulder’s Institute of Cognitive Science (ICS) and the Psychology and Neuroscience Department. CANLab uses machine-learning to develop fMRI-based biomarkers for clinically relevant outcomes, such as pain. It subsequently tests how psychological factors influence these biomarkers. The lab also engages in collaborative, translational research, which incorporates brain systems-level analyses into the study of clinical disorders, including PTSD, depression, schizophrenia, and chronic pain.

Learn more about CAN Lab at https://canlabweb.colorado.edu

About cliexa
The mobile platform technology developed by cliexa enables patients to track their chronic disease activity by quantifying symptoms using scientifically-proven and clinically-validated scoring models. cliexa delivers quantified disease activity and medication adherence through patient reported outcomes through real-time integration to electronic medical records, which streamline processes and increase efficiency in population health management.

Learn more about cliexa at https://www.cliexa.com

See the Press release here: